by TractManager | May 8, 2024 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of RevitalVision for treatment of amblyopia in individuals aged 9 years or older.
by TractManager | May 8, 2024 | Emerging Technology Report
The AGENT Drug-Coated Balloon (Boston Scientific Corp.) is a paclitaxel-coated balloon catheter indicated for treatment of coronary in-stent restenosis (ISR). It is intended to be used after appropriate vessel preparation in adult patients undergoing percutaneous...
by TractManager | May 7, 2024 | Emerging Technology Report
The dNerva Lung Denervation System (Nuvaira Inc.) is an investigational, bronchoscopic catheter-based pulmonary nerve ablation system proposed to reduce the frequency and severity of chronic obstructive pulmonary disease (COPD) exacerbations.
by TractManager | May 6, 2024 | Emerging Technology Report
The aXess graft (Xeltis) is a synthetic bioresorbable vascular conduit under investigation to establish arteriovenous access for hemodialysis in patients with end-stage renal disease.
by TractManager | May 2, 2024 | Emerging Technology Report
Prademagene zamikeracel (pz-cel; formerly EB-101) (Abeona Therapeutics Inc.) is a gene-corrected epidermal sheet under investigation for the treatment recessive dystrophic epidermolysis bullosa.
Recent Comments